Ammendolia, I.; Mannucci, C.; Esposito, E.; Calapai, G.; Currò, M.; Midiri, P.; Mondello, C.; Cardia, L.; Calapai, F.
Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis. Pharmaceuticals 2025, 18, 702.
https://doi.org/10.3390/ph18050702
AMA Style
Ammendolia I, Mannucci C, Esposito E, Calapai G, Currò M, Midiri P, Mondello C, Cardia L, Calapai F.
Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis. Pharmaceuticals. 2025; 18(5):702.
https://doi.org/10.3390/ph18050702
Chicago/Turabian Style
Ammendolia, Ilaria, Carmen Mannucci, Emanuela Esposito, Gioacchino Calapai, Mariaconcetta Currò, Paola Midiri, Cristina Mondello, Luigi Cardia, and Fabrizio Calapai.
2025. "Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis" Pharmaceuticals 18, no. 5: 702.
https://doi.org/10.3390/ph18050702
APA Style
Ammendolia, I., Mannucci, C., Esposito, E., Calapai, G., Currò, M., Midiri, P., Mondello, C., Cardia, L., & Calapai, F.
(2025). Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis. Pharmaceuticals, 18(5), 702.
https://doi.org/10.3390/ph18050702
